Article

Malignant melanoma in transplant patients: a case report and review of the literature.

University of Notre Dame, Indiana, USA.
Cutis; cutaneous medicine for the practitioner (impact factor: 0.81). 03/2012; 89(3):133-6. pp.133-6
Source: PubMed

ABSTRACT The clinical course and outcome of malignant melanoma (MM) are well-established for immunocompetent groups; however, they are not well-documented for immunosuppressed populations. Specifically, the influence of immunosuppression may result in poorer outcomes, especially in more advanced cases of melanoma. We report a 67-year-old woman who had previously undergone a kidney and pancreas transplant and presented with American Joint Committee on Cancer (AJCC) stage IIIA melanoma with subsequent rapid demise. As medicine advances with greater numbers of organ transplant recipients, a multi-institutional prospective study for this at-risk population would be greatly beneficial to help characterize the incidence, progression, and prognosis of melanoma in posttransplant immunosuppressed populations.

0 0
 · 
0 Bookmarks
 · 
43 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

67-year-old woman
 
American Joint Committee
 
clinical course
 
greater numbers
 
immunocompetent groups
 
malignant melanoma
 
organ transplant recipients
 
poorer outcomes
 
prognosis
 
subsequent rapid demise
 

A Nichole Sullivan